Treatment Effectiveness of Azithromycin and Doxycycline in Uncomplicated Rectal and Vaginal Chlamydia trachomatis Infections in Women: A Multicenter Observational Study (FemCure)

We demonstrated that in 416 women attending a sexually transmitted infection clinic, microbiological cure was low in azithromycin-treated (78.5%) compared with doxycycline-treated (95.5%) rectal chlamydia; microbiological cure in vaginal chlamydia was high for both treatment types (93.5% and 95.4%).

[1]  C. Hoebe,et al.  Review of Chlamydia trachomatis viability methods: assessing the clinical diagnostic impact of NAAT positive results , 2018, Expert review of molecular diagnostics.

[2]  J. Hocking,et al.  The efficacy of azithromycin and doxycycline treatment for rectal chlamydial infection: a retrospective cohort study in South Australia , 2018, Internal medicine journal.

[3]  Nastassya L Chandra,et al.  Detection of Chlamydia trachomatis in rectal specimens in women and its association with anal intercourse: a systematic review and meta-analysis , 2018, Sexually Transmitted Infections.

[4]  C. Foschi,et al.  Chlamydia trachomatis antimicrobial susceptibility in colorectal and endocervical cells , 2018, The Journal of antimicrobial chemotherapy.

[5]  K. Bernstein,et al.  Prevalence of Rectal Chlamydial and Gonococcal Infections: A Systematic Review , 2017, Sexually transmitted diseases.

[6]  C. Mercer,et al.  Heterosexual Practices Among Young People in Britain: Evidence From Three National Surveys of Sexual Attitudes and Lifestyles , 2017, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[7]  S. Bruisten,et al.  Monitoring therapy success of urogenital Chlamydia trachomatis infections in women: A prospective observational cohort study , 2017, PloS one.

[8]  Suzanna C Francis,et al.  Sexually transmitted infections: challenges ahead. , 2017, The Lancet. Infectious diseases.

[9]  C. Hoebe,et al.  High Proportion of Anorectal Chlamydia trachomatis and Neisseria gonorrhoeae After Routine Universal Urogenital and Anorectal Screening in Women Visiting the Sexually Transmitted Infection Clinic , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  T. Wong,et al.  Benefit of adjunct universal rectal screening for Chlamydia genital infections in women attending Canadian sexually transmitted infection clinics , 2017, International journal of STD & AIDS.

[11]  A. McNulty,et al.  Treatment efficacy of azithromycin 1 g single dose versus doxycycline 100 mg twice daily for 7 days for the treatment of rectal chlamydia among men who have sex with men – a double-blind randomised controlled trial protocol , 2017, BMC Infectious Diseases.

[12]  Johannes A Bogaards,et al.  What explains anorectal chlamydia infection in women? Implications of a mathematical model for test and treatment strategies , 2016, Sexually Transmitted Infections.

[13]  C. Hoebe,et al.  Viability-PCR Shows That NAAT Detects a High Proportion of DNA from Non-Viable Chlamydia trachomatis , 2016, PloS one.

[14]  H. Ward,et al.  Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark. , 2016, The Lancet. Infectious diseases.

[15]  G. Kok,et al.  Design of the FemCure study: prospective multicentre study on the transmission of genital and extra-genital Chlamydia trachomatis infections in women receiving routine care , 2016, BMC Infectious Diseases.

[16]  K. Chapin,et al.  Extragenital Infections Caused by Chlamydia trachomatis and Neisseria gonorrhoeae: A Review of the Literature , 2016, Infectious diseases in obstetrics and gynecology.

[17]  J. Hocking,et al.  Higher organism load associated with failure of azithromycin to treat rectal chlamydia , 2016, Epidemiology and Infection.

[18]  S. Plitt,et al.  A Retrospective Review of Treatment Failures Using Azithromycin and Doxycycline in the Treatment of Rectal Chlamydia Infections in Women and Men Who Have Sex With Men. , 2016, Sexually transmitted diseases.

[19]  M. Unemo,et al.  2015 European guideline on the management of Chlamydia trachomatis infections , 2010, International journal of STD & AIDS.

[20]  P. Kerndt,et al.  Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection. , 2015, The New England journal of medicine.

[21]  C. Hoebe,et al.  What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion , 2015, BMC Infectious Diseases.

[22]  J. Hocking,et al.  The efficacy of azithromycin and doxycycline for the treatment of rectal chlamydia infection: a systematic review and meta-analysis. , 2015, The Journal of antimicrobial chemotherapy.

[23]  J. Hocking,et al.  Treatment of rectal chlamydia infection may be more complicated than we originally thought. , 2014, The Journal of antimicrobial chemotherapy.

[24]  R. Guy,et al.  Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  R. Challenor,et al.  Rectal Chlamydia in heterosexual women: more questions than answers , 2014, International journal of STD & AIDS.

[26]  C. Hoebe,et al.  Detection of Anorectal and Cervicovaginal Chlamydia Trachomatis Infections following Azithromycin Treatment: Prospective Cohort Study with Multiple Time-Sequential Measures of rRNA, DNA, Quantitative Load and Symptoms , 2013, PloS one.

[27]  M. Golden,et al.  Suboptimal adherence to doxycycline and treatment outcomes among men with non-gonococcal urethritis: a prospective cohort study , 2013, Sexually Transmitted Infections.

[28]  S. Bruisten,et al.  Distinct Transmission Networks of Chlamydia trachomatis in Men Who Have Sex with Men and Heterosexual Adults in Amsterdam, The Netherlands , 2013, PloS one.

[29]  P. Horner.  Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy , 2012, Sexually Transmitted Infections.

[30]  Latif As,et al.  Guidelines for the management of sexually transmitted infections. , 2012 .

[31]  M. Unemo,et al.  European Guideline for the Management of Chlamydia Trachomatis Infections , 2022 .

[32]  P. Horner,et al.  The case for further treatment studies of uncomplicated genital Chlamydia trachomatis infection , 2006, Sexually Transmitted Infections.

[33]  E. Hook,et al.  Compliance With Doxycycline Therapy in Sexually Transmitted Diseases Clinics , 1998, Sexually transmitted diseases.